Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Other Working Capital Changes of -$3.5 million in Q3 2025, down 311.39% quarter-over-quarter from $1.7 million in Q2 2025, and down 861.37% on a YoY basis from $460879.8 in Q3 2024.
Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2014 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Other Working Capital Changes history runs 12 years deep, the most recent figure standing at -$3.5 million for Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 861.37% year-over-year to -$3.5 million; the TTM figure through Sep 2025 stood at -$1.6 million (down 60.43% YoY), while the FY2024 annual figure was -$1.4 million, down 197.76% from the prior year.
- Other Working Capital Changes was -$3.5 million for Q3 2025 at Corbus Pharmaceuticals Holdings, down from $1.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.0 million in Q3 2023 to a low of -$3.5 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged -$191673.6 across 5 years, with a median of -$289002.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes jumped 792.38% in 2023, then plunged 861.37% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$604389.0 in 2021, then soared by 51.22% to -$294821.0 in 2022, then jumped by 131.54% to $93000.0 in 2023, then slumped by 498.92% to -$371000.0 in 2024, then slumped by 845.82% to -$3.5 million in 2025.
- The last three Other Working Capital Changes figures came in at -$3.5 million (Q3 2025), $1.7 million (Q2 2025), and $659000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.51 Mn |
| Sep 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 659,000.00 |
| Mar 31, 2025 | 659,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Jun 30, 2024 | 528,000.00 |
| Jun 30, 2024 | 528,000.00 |
| Mar 31, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Dec 31, 2023 | 93,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Sep 30, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | -1.19 Mn |
| Jun 30, 2023 | -1.19 Mn |